First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital

Anaerobe

Volumn 30, Issue , 2014, Pages 18-23

  Novak, Anita ^a,b   Spigaglia, Patrizia ^c   Barbanti, Fabrizio ^c   Goic Barisic, Ivana ^a,b   Tonkic, Marija ^a,b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antimicrobial susceptibility; Clostridium difficile infection; Molecular epidemiology

Indexed keywords

AMINOPENICILLIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; ERYTHROMYCIN; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; COTRIMOXAZOLE; GATIFLOXACIN; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; MEROPENEM; MOXIFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ACQUIRED INFECTION; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CROATIA; ENZYME IMMUNOASSAY; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; RIBOTYPING; SCHOOL CHILD; STRAIN IDENTIFICATION; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; ADOLESCENT; AGED; CLASSIFICATION; CLOSTRIDIUM INFECTION; CROSS INFECTION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PREVALENCE; PROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; CROATIAN (CITIZEN); DIARRHEA; DRUG HYPERSENSITIVITY; HEALTH CARE; INFECTION; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; ONSET AGE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROATIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROTOXINS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; RIBOTYPING; YOUNG ADULT;

EID: 84905698905     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2014.07.007     Document Type: Article

References (30)

1. Bartlett J.G. Clostridium difficile: progress and challenges. Ann N Y Acad Sci 2010, 1213:62-69.
2. Kelly C.P., LaMont J.T. Clostridium difficile-more difficult than ever. NEngl J Med 2008, 359:1932-1940.
3. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455. Society for Healthcare Epidemiology of America, Infectious Diseases Society of AmericaInfectious Diseases Society of America.
4. Bartlett J.G., Gerding D.N. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008, 46:S12-S18.
5. Freeman J., Bauer M.P., Baines S.D., Corver J., Fawley W.N., Goorhuis B., et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010, 23:529-549.
6. Depestel D.D., Aronoff D.M. Epidemiology of Clostridium difficile infection. JPharm Pract 2013, 26:464-475.
7. Jones A.M., Kuijper E.J., Wilcox M.H. Clostridium difficile: a European perspective. JInfect 2013, 66:115-128.
8. Cartman S.T., Heap J.T., Kuehne S.A., Cockayne A., Minton N.P. The emergence of "hypervirulence" in Clostridium difficile. Int J Med Microbiol 2010, 300:387-395.
9. Bauer M.P., Notermans D.W., van Benthem B.H.B., Brazier J.S., Wilcox M.H., Rupnik M., et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73. ECDIS Study Group.
10. Barbut F., Jones G., Eckert C. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis 2011, 24:370-376.
11. Goorhuis A., Bakker D., Corver J., Debast S.B., Harmanus C., Notermans D.W., et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008, 47:1162-1170.
12. Kuijper E.J., van Dissel J.T. Spectrum of Clostridium difficile infections outside health care facilities. Can Med Assoc J 2008, 179:747-748.
13. Chitnis A.S., Holzbauer S.M., Belflower R.M., Winston L.G., Bamberg W.M., Lyons C., et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 2013, 173:1359-1367.
14. Candiotto A., Pascoli I., Gritti A., Busato E., Dal Pozzo G. Toxic megacolon complicating a Clostridium difficile infection in a pregnant woman. JMed Microbiol 2009, 59:124-126.
15. Khanna S., Pardi D.S., Aronson S.L., Kammer P.P., Orenstein R., St Sauver J.L., et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012, 107:89-95.
16. Miyajima F., Roberts P., Swale A., Price V., Jones M., Horan M., et al. Characterization and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom. PLoS One 2011, 6(8):e22804.
17. Wilcox M.H., Mooney L., Bendall R., Settle C.D., Fawley W.N. Acase-control study of community-associated Clostridium difficile infection. JAntimicrob Chemother 2008, 62:388-396.
18. European Commission Commission staff working document: detailed analysis of countries' reports on the implementation of the Council Recommendation (2009/C151/01) on patient safety, including the prevention and control of healthcare associated infections SWD (2012) 366 final 2012, Brussels, EU.
19. Suetens C. Clostridium difficile: summary of actions in the European Union. Eurosurveillance 2008, 13:1-2.
20. Kuijper E.J., Coignard B., Tüll P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12:2-18. on behalf of the ESCMID Study Group for Clostridium difficile EU Member States; European Centre for Disease Prevention and Control.
21. Bauer M.P., Kuijper E.J., van Dissel J.T. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009, 15:1067-1079.
22. Clinical and Laboratory Standards Institute Methods for antimicrobial susceptibility testing of anaerobic bacteria-seventh edition: approved standard M11-A7 2007, CLSI, Wayne, PA, USA.
23. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18 2008, CLSI, Wayne, PA, USA.
24. Bidet P., Lalande V., Salauze B., Burghoffer B., Avesani V., Delmée M., et al. Comparison of PCR-ribotyping, arbitrarily primed PCR and pulsed-field gel electrophoresis for typing Clostridium difficile. JClin Microbiol 2000, 38:2484-2487.
25. Indra A., Huhulescu S., Schneeweis M., Hasenberger P., Kernbichler S., Fiedler A., et al. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. JMed Microbiol 2008, 57:1377-1382.
26. UK Department of Health Update guidance on the diagnosis and report of Clostridium difficile 2012, Published to DH website. http://www.dh.gov.uk/publications.
27. Pirš T., Avberšek J., Zdovc I., Krt B., Andlovic A., Lejko-Zupanc T., et al. Antimicrobial susceptibility of animal and human isolates of Clostridium difficile by broth microdilution. JMed Microbiol 2013, 62:1478-1485.
28. Spigaglia P., Barbanti F., Mastrantonio P. Multidrug resistance in European Clostridium difficile clinical isolates. JAntimicrob Chemother 2011, 66:2227-2234. European Study Group on Clostridium difficile (ESGCD).
29. Spigaglia P., Barbanti F., Mastrantonio P., Brazier J.S., Barbut F., Delmée M., et al. Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C.difficile infections in Europe. JMed Microbiol 2008, 57:784-789. on behalf of the European Study Group on Clostridium difficile (ESGCD).
30. Payerl Pal M., Tambic Andrasevic A. Antibiotic consumption in Croatia. Antibiotic resistance in Croatia, 2011 2012, 132-138. The Croatian Academy of Medical Science, Zagreb, Croatia. A. Tambic Andrasevic, T. Tambic, V. Katalinic-Jankovic, M. Payerl Pal, S. Bukovski, S. Soprek (Eds.).